BioCentury
ARTICLE | Management Tracks

McKinsey vet Dewhurst joins Lightrock

Plus: Wugen appoints Alles as chair and updates from Cerevel, Ribbon, Immodulon and more

May 11, 2023 12:04 AM UTC

Martin Dewhurst announced on LinkedIn that he has joined Lightrock, a London-based global impact investor. Dewhurst established and co-led the McKinsey Health Institute, and worked at the consulting company for over 30 years. 

NK and CAR T cell company  Wugen Inc. appointed Mark Alles to succeed Natalie Mount as chair. Alles was chairman and CEO at Celgene Corp., and has served on the boards of Turning Point Therapeutics Inc., PhRMA, the European Federation of Pharmaceutical Industries and Associations (EFPIA) and BIO. Mount will become a director. ...